A new twist on a decades-old anticancer strategy has shown powerful effects against multiple cancer types in a preclinical ...

A new twist on a decades-old anticancer strategy has shown powerful effects against multiple cancer types in a preclinical ...

T cell-based immunotherapies, including CAR-T cell therapies, have significantly advanced treatment options for lymphomas such as diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL).

TPU scientists have synthesized new organic compounds that could potentially be used to develop drugs against prostate ...

Researchers from POSTECH and Kyungpook National University have developed a novel inhalable therapeutic delivery system for ...

An analysis of oncology drugs approved in the United States found that Medicare spending was predominantly driven by the market, not a drug’s therapeutic value.

Southern Medical University scientists have reported the discovery and preclinical characterization of novel microtubule-inhibiting agents being developed for the treatment of cancer.

According to the National Confectioners Association, the highest candy cane sales occur in the second week in December, so there’s a good chance you will encounter the festive treats in the coming ...

Anticancer Peptide Market Offers US$ 18 Billion Opportunity Says Kuick Research. Delhi, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The ...

For her senior project, she investigated if Ruthenium (II) metal centers could present promising candidates for novel ...

A study shares new insights into how two of the most common types of chimeric antigen receptor (CAR) T cells kill cancer. Investigators examined how molecular dynamics at the immune synapse -- where ...